O

Oric Pharmaceuticals
D

ORIC

13.540
USD
-0.36
(-2.59%)
مفتوح الان
حجم التداول
403
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
1,315,045,244
أصول ذات صلة الأخبار المقالات

العنوان: Oric Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.